KALY’s proprietary CBD formulation has been developed for the treatment of symptoms associated with COPD
US based Puration, Inc. and Kali-Extracts have announced that PURA has acquired KALY’s Hemp4mula CBD Confections business.
The Hemp4mula CBD Confections line today sells CBD infused gummies and gum. KALY is selling the operation to streamline its focus on its ongoing cannabis biopharmaceutical business.
KALY’s proprietary CBD formulation has been developed for the treatment of symptoms associated with Chronic Obstructive Pulmonary Disease (COPD) and other similar respiratory conditions.
KALY has filed a new patent application specifically on its CBD formulation for symptoms associated with COPD and other similar respiratory conditions. KALY has also filed for a trademark on the name RespRx as the brand name for its CBD formulation to treat the symptoms associated with COPD and other similar respiratory conditions that result from respiratory inflammation.
PURA recently launched a campaign to acquire CBD infused beverage, edible and topical operations and also announced closing on a $5 million investment to fund the acquisition campaign. The $5 million investment is structured as a debt facility whereby funds can be drawn as needed to fund acquisitions. The drawn funds would be secured by the acquired asset and the debt can be repaid in stock at $0.10 per share.